AEZS/KERX
That article is complete crap and from a notorious pump and dumper. Sure, the trial could possibly be positive, but it is based on a very shaky phase 2 foundation and approval couldn't be much further from a "done deal"
Opinions and comments may have been previously posted @BioDueDiligence, at www.biotechduediligence.com, or disseminated to Chimera Research Group subscribers.